GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $7,000 | 0.0% | 164 | +1.2% | 0.00% | 0.0% |
Q1 2017 | $7,000 | +16.7% | 162 | +1.2% | 0.00% | 0.0% |
Q4 2016 | $6,000 | -14.3% | 160 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $7,000 | 0.0% | 160 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $7,000 | -75.0% | 160 | -77.1% | 0.00% | -80.0% |
Q1 2016 | $28,000 | 0.0% | 700 | +1.3% | 0.01% | -28.6% |
Q4 2015 | $28,000 | +7.7% | 691 | +1.5% | 0.01% | +16.7% |
Q3 2015 | $26,000 | -7.1% | 681 | +1.5% | 0.01% | 0.0% |
Q2 2015 | $28,000 | -62.2% | 671 | -57.9% | 0.01% | -77.8% |
Q1 2015 | $74,000 | +89.7% | 1,594 | +76.5% | 0.03% | +80.0% |
Q4 2014 | $39,000 | -4.9% | 903 | +1.5% | 0.02% | -16.7% |
Q3 2014 | $41,000 | -4.7% | 890 | +11.2% | 0.02% | 0.0% |
Q2 2014 | $43,000 | -17.3% | 800 | -18.5% | 0.02% | -21.7% |
Q1 2014 | $52,000 | 0.0% | 982 | 0.0% | 0.02% | 0.0% |
Q4 2013 | $52,000 | +6.1% | 982 | 0.0% | 0.02% | +4.5% |
Q3 2013 | $49,000 | -23.4% | 982 | -23.4% | 0.02% | -29.0% |
Q2 2013 | $64,000 | – | 1,282 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |